A double-blind, randomized, placebo-controlled study of daily drospirenone/estradiol evaluating the pharmacokinetic/pharmacodynamic properties in postmenopausal women with moderate to severe vasomotor symptoms
Latest Information Update: 03 Dec 2015
At a glance
- Drugs Estradiol/drospirenone (Primary)
- Indications Vasomotor symptoms
- Focus Pharmacodynamics; Pharmacokinetics
Most Recent Events
- 03 Dec 2015 New trial record